The role of magnesium sulfate in acute asthma: does route of administration make a difference?

Colin V E Powell1

  • 1Noah Ark Children's Hospital for Wales, Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Cardiff, Wales, UK.

Abstract

Insights

Magnesium sulfate (MgSO4) offers limited benefit for acute asthma, primarily aiding severe exacerbations. Intravenous (i.v.) administration is more effective in adults, with future research focusing on severe cases.

Area of Science:

  • Pulmonology
  • Emergency Medicine
  • Pharmacology

Background:

  • The efficacy of magnesium sulfate (MgSO4) in acute asthma treatment remains debated.
  • Previous systematic reviews indicate a restricted role for both intravenous (i.v.) and inhaled nebulized MgSO4.

Purpose of the Study:

  • To synthesize current literature on MgSO4 for acute asthma.
  • To analyze findings from two major multicenter randomized controlled trials.
  • To identify future research avenues for MgSO4 in asthma management.

Main Methods:

  • Review of recent systematic reviews and two large multicenter randomized controlled trials (MAGNETIC and 3Mg).
  • Analysis of data comparing nebulized and i.v. MgSO4 administration routes.
  • Focus on patient subgroups, including children and adults with varying asthma severity.

Main Results:

  • The MAGNETIC trial found minimal benefit of nebulized MgSO4 in children, except possibly in severe, short-duration exacerbations.
  • The 3Mg trial demonstrated no benefit of nebulized MgSO4 in adults and a limited role for i.v. MgSO4 in the most severe cases.
  • Intravenous (i.v.) MgSO4 showed a potential benefit in severe adult asthma exacerbations.

Conclusions:

  • Magnesium sulfate (MgSO4) is indicated for severe acute asthma exacerbations; its use in milder cases lacks evidence.
  • Both i.v. and nebulized MgSO4 are well-tolerated and cost-effective treatments.
  • Intravenous administration is preferred in adults, while further research is needed for pediatric severe exacerbations.

Related Concept Videos

Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
5.3K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
2.0K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.1K
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
572